Amyotrophic lateral sclerosis, dysarthria, and language disorders - type of research and approaches in different areas: an integrative literature review
Esclerose lateral amiotrófica, disartria e alterações de linguagem - tipo de pesquisa e abordagens em diferentes áreas: revisão integrativa da literatura
Lavoisier Leite Neto; Marcondes Cavalcante França Júnior; Regina Yu Shon Chun
Abstract
Purpose: to identify the knowledge produced in national and international researches on speech and language disorders in Amyotrophic Lateral Sclerosis, regarding the type of research and approach in different areas.
Methods: an integrative review performed on databases, using the following descriptors: Amyotrophic Lateral Sclerosis, Dysarthria, Language Disorders, Speech Production Measurement and Speech Disorders. The inclusion criteria covered articles that addressed motor speech and language disorders from 2013 to 2018, excluding duplications, and categorizing valid articles for analysis.
Results: 83 articles were selected, after screening the titles and abstracts. A large scientific production from different countries and areas, mainly Speech Therapy and Neurology, was found. Most of them was clinical research (65.06%), with a main focus on speech motor disorders (42.16%), speech and language motor disorders, cognition and behavior (27.71%), and language disorders (12.06%).
Conclusion: researches found were mostly clinical and aimed at determining the diagnosis of disorders in different areas of knowledge. With regard to communication, few studies have been found in Brazil, and international studies addressed high technology. The results confirmed the heterogeneous nature of the disease, which shows, in addition to motor impairment of speech, cognitive, behavioral and language impairments.
Keywords
Resumo
Objetivo: identificar o conhecimento produzido em pesquisas nacionais e internacionais das alterações de fala e de linguagem na Esclerose Lateral Amiotrófica, quanto tipo de pesquisa e abordagens em diferentes áreas.
Métodos: revisão integrativa realizada em bases de dados, utilizando-se os descritores Amyotrophic Lateral Sclerosis, Dysarthria, Language Disorders, Speech Production Measurement e Speech Disorders. Os critérios de inclusão abrangeram artigos que abordassem alterações motoras de fala e de linguagem de 2013 a 2018, excluindo-se duplicações, categorizando-se os válidos para análise.
Resultados: selecionou-se 83 artigos, após triagem dos títulos e resumos. Foi encontrada grande produção científica de diferentes países e áreas, principalmente Fonoaudiologia e Neurologia, na maioria pesquisas clínicas (65,06%), com foco principal em alterações motoras da fala (42,16%), alterações motoras de fala e linguagem, cognição e comportamento (27,71%) e alterações de linguagem (12,06%).
Conclusão: as pesquisas encontradas foram, na maioria, clínicas e com objetivo determinar diagnóstico das alterações em diferentes áreas do conhecimento. No que se refere à comunicação, foram encontrados poucos estudos no Brasil e os internacionais voltavam-se à alta tecnologia. Os resultados confirmaram o caráter heterogêneo doença, que evidencia, além de comprometimento motor da fala, prejuízo cognitivo, comportamental e de linguagem.
Palavras-chave
Referências
1. Hardiman O, Al-Chalabi A, Chio A, Hyde EM, Zacco D, Van Den Berg LH et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71
2. Beghi E, Logroscino G, Chio A, Hardiman O, Millul A, Mitchell D et al. Amyotrophic lateral sclerosis, occupational exposure to metals and poycyclic aromatic hydrocarbons and genetic polymorphisms. Amyotroph Lateral Scler Frontotemporal Degener. 2011;12(1):41-9. doi: 10.3109/17482968.2010.522536
3. Van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084-98. doi: 10.1016/S0140-6736(17)31287-4
4. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-55. doi: 10.1016/S0140-6736(10)61156-7
5. Gordon PH. Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis. 2013;4(5):295-310. doi: 10.14336/AD.2013.0400295
6. Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118-30. doi: 10.1159/000351153
7. Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918-29. doi: 10.1111/ene.14393
8. Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC. Bradley’s Neurology in clinical practice. 6th ed. Philadelphia: Elsevier Saunders; 2012.
9. Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. 3rd ed. St. Louis: Elsevier Mosby; 2013.
10. Freed DB. Motor speech disorders: diagnosis and treatment. 3rd ed. San Diego: Plural Publishing; 2020.
11. Beukelman DR, Fager S, Nordness A. Communication support for people with ALS. Neurol Res Int. 2011;2011:714693. doi: 10.1155/2011/714693
12. Strong MJ, Abrahams S, Goldstein LH, Smith S, Taylor JP, Hood B et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3-4):153-74. doi: 10.1080/21678421.2016.1267768
13. Taylor JP, Brown Jr RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197-206. doi: 10.1038/nature20413
14. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosier JT, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65(4):586-90. doi: 10.1212/01.wnl.0000172911.39167.b9
15. Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N et al. Executive dysfunction in ALS: a population-based study. Neurology. 2011;76(14):1259-65. doi: 10.1212/WNL.0b013e31821435b6
16. Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G et al. Cognitive impairment in amyotrophic lateral sclerosis: a property of anatomical phenotype or severity of disease? J Neurol Neurosurg Psychiatry. 2015;86(1):114-6. doi: 10.1136/jnnp-2013-307221
17. Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2013;84(5):494-8. doi: 10.1136/jnnp-2012-303528
18. Mendes BCA, Oliveira ASB, Atallah AN. Fonoaudiologia e esclerose lateral amiotrófica. In: Ferreira LP, Befi-Lopes DM, Limongi SCO (orgs). Tratado de fonoaudiologia. São Paulo: Roca; 2004. p. 433-41.
19. Mendes BCA, Marchesan IQ, Atallah AN, Oliveira ASB. Fonoaudiologia e esclerose lateral amiotrófica: revisão sistemática. In: Marchesan IQ, Bolaffi C, Gomes ICD, Zorzi JL (orgs). Tópicos em fonoaudiologia 2005. Rio de Janeiro: Revinter; 2005. p. 119-35.
20. Donaghy C, Pinnock R, Abrahams S, Cardwell C, Hardiman O, Patterson V et al. Slowing of eye movements, cognitive impairment and anatomical phenotype in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(3):347-53. doi: 10.1136/jnnp.2010.211912
21. Raaphorst J, Beeldman E, Schmand B, Berkhout J, Linssen WHJP, de Visser M et al. The cognitive and behavioral spectrum of amyotrophic lateral sclerosis: a critical review of the prevalence and spectrum of frontotemporal dementia in ALS. Eur J Neurol. 2012;19(9):1165-71. doi: 10.1111/j.1468-1331.2012.03659.x
22. Mendes BCA, Oliveira ASB, Atallah AN. Esclerose lateral amiotrófica. In: Campiotto AR, Levy CCAC, Redondo MC, Anelli W (orgs). Tratado de fonoaudiologia. São Paulo: Roca; 2014. p. 651-60.
23. Mendes BCA. Intervenção fonoaudiológica em pacientes com Esclerose Lateral Amiotrófica. In: Pernambuco LA, Silva HJ, Cunha DA (orgs). Fonoaudiologia nas unidades de terapia intensiva. Rio de Janeiro: Revinter; 2015. p. 143-55.
24. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546-53. doi: 10.1111/j.1365-2648.2005.03621.x
25. Peterson J, Pearce PF, Ferguson LA, Langford CA. Understanding integrative reviews: insights and strategies, from concept to publication. J Am Assoc Nurse Pract. 2017;29(5):273-9. doi: 10.1002/2327-6924.12462
26. Mendes KDS, Silveira RCCP, Galvão CM. Integrative literature review: a research method to incorporate evidence in health care and nursing. Texto contexto - enferm. 2008;17(4):758-64. doi: 10.1590/S0104-07072008000400018
27. Galvão TF, Pereira MG. Revisões sistemáticas da literatura: passos para sua elaboração. Epidemiol. Serv. Saúde. 2014;23(1):183-4. doi: 10.5123/S1679-49742014000100018
28. Ash S, Moore P, Antani S, McCawley G, Work M, Grossman M. Trying to tell a story: Neuropathological associations of narrative discourse in frontotemporal dementia. Neurology. 2006;66(9):1403-10. doi: 10.1212/01.wnl.0000210433.15582.4e
29. Abrahams S, Goldstein LH, Al-Chalabi A, Pickering A, Morris RG, Passingham RE et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997;62(5):464-72. doi: 10.1136/jnnp.62.5.464
30. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grisé D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38(6):734-47. doi: 10.1016/S0028-3932(99)00146-3
31. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102-8. doi: 10.1136/jnnp-2011-300188
32. Yorkston KM, Strand E, Miller R, Hillel A, Smith K. Speech deterioration in amyotrophic lateral sclerosis: implications for the timing of intervention. J Med Speech Lang Pathol. 1993;1:35-46.
33. Taylor LJ, Goldstein LH, Albrighton L, Leigh PN, Brown RG. Sentence length and syntax as markers of cognitive impairment in Amyotrophic Lateral Sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(11):1208-15. doi: 10.1136/jnnp-2014-309290
34. Tsermentseli S, Leigh PN, Taylor LJ, Radunovic A, Catani M, Goldstein LH. Syntactic processing as a marker for cognitive impairment in Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):69-76. doi: 10.3109/21678421.2015.1071397
35. Leslie FV, Hsieh S, Caga J, Savage SA, Mioshi E, Hornberger M et al. Semantic deficits in Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1-2):46-53. doi: 10.3109/21678421.2014.987301
36. Ash S, Olm C, McMillan CT, Boller A, Irwin DJ, McCluskey L et al. Deficits in sentence expression in Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1-2):31-9. doi: 10.3109/21678421.2014.987301
Submetido em:
15/05/2020
Aceito em:
13/08/2020
Facebook
Twitter
LinkedIn
Mendeley
Email